: Factor VIII Inhibitor, Bethesda Assay (Coagulation, Plasma)

: What This Test Measures

: Factor VIII is a protein that helps blood clot. Some people develop antibodies, called inhibitors, that attach to factor VIII and reduce its ability to work. This test mixes the patient's plasma with known factor VIII to estimate how much inhibitor activity is present. Results are usually expressed in Bethesda units, but the specific cutoff values depend on the laboratory.

: Why It May Be Ordered

: The test is most often ordered when a person with hemophilia A stops responding to factor VIII replacement, or when bleeding does not improve as expected after treatment. It may also be checked before surgery or during monitoring of immune tolerance therapy. Your care team uses the result together with factor VIII levels and your symptoms.

: How the Sample Is Collected

: A blood sample is drawn from a vein into a tube containing an anticoagulant, typically sodium citrate. Proper collection and timely processing matter because clotting tests are sensitive to how the sample is handled. No special preparation is usually required, but follow any instructions from your care team.

: What Results Can Mean

: A low or undetectable inhibitor level generally suggests inhibitors are not a major problem. A higher level indicates that inhibitor antibodies are present and may interfere with factor VIII therapy. Results are reported in categories such as low-responding or high-responding inhibitors, but the exact thresholds vary by laboratory and should be interpreted by your clinician.